Efficacy of modest dose irradiation in combination with long-term endocrinal treatment for high-risk prostate cancer: A preliminary report

Tomonari Sasaki, Katsumasa Nakamura, Yoshiyuki Shioyama, Saiji Ohga, Yusuke Urashima, Hiromi Terashima, Hirofumi Koga, Seiji Naito, Hideya Noma, Kiyoshi Komatsu, Akito Yamaguchi, Hiroshi Honda

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

Background: Although radiotherapy in combination with endocrinal manipulation has been identified as an effective treatment for patients with high-risk prostate cancer, the optimal dose for locoregional control of prostate cancer in combination with hormonal therapy has not yet been determined. Methods: The efficacy of modest doses of irradiation (60-62 Gy) combined with long-term endocrinal treatment for patients with high-risk prostate cancer (defined as a pretreatment prostate-specific antigen (PSA) level greater than 20 ng/ml or a Gleason's score of 8-10 or T3-T4 disease) was analyzed in 60 Japanese patients. The patients included in this study had received radical radiotherapy with long-term endocrinal manipulation in the period between 1993 and 2000. The median age of the patients was 70 years (range, 56-83). Neoadjuvant hormonal therapy with a median duration of 3.9 months was performed prior to radiotherapy, and hormonal therapy was continued until recurrence. A median dose of 61.4 Gy (range, 44-71.4) was delivered to the prostate. Pelvic node irradiation was performed in 49 patients (81.6%). Results: After a median follow-up period of 28.5 months, the overall survival, cause-specific survival and biochemical relapse-free survival at 3 years were 94.4%, 96% and 89.8%, respectively. Local failure was observed in one patient, distant metastases were observed in three patients and a late toxic effect greater than Grade 2 was not observed in any patients. Conclusions: This study, though preliminary due to a short-term follow-up period, reveals the possibility that modest doses of irradiation combined with long-term endocrinal treatment could be an effective means of achieving excellent local control of high-risk prostate cancer.

Original languageEnglish
Pages (from-to)420-424
Number of pages5
JournalJapanese journal of clinical oncology
Volume34
Issue number7
DOIs
Publication statusPublished - Jul 1 2004

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'Efficacy of modest dose irradiation in combination with long-term endocrinal treatment for high-risk prostate cancer: A preliminary report'. Together they form a unique fingerprint.

Cite this